John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
PUT
Alaska Air
ALK
$4.84B
| $853K | ﹤0.01% |
16,400
-7,200
| -31% | -$324K |
|
|
CYPH
2127
Cypherpunk Technologies Inc
CYPH
$177M
| $853K | ﹤0.01% |
37,911
-1,880
| -5% | -$35.8K |
|
2128
CALL
Dillards
DDS
$9.95B
| $851K | ﹤0.01% |
13,500
+6,500
| +93% | +$318K |
|
2129
XP
XP
$9.03B
| $849K | ﹤0.01% |
+21,413
| New | +$875K |
|
|
GNCA
2130
DELISTED
Genocea Biosciences, Inc.
GNCA
| $845K | ﹤0.01% |
349,244
+167,234
| +92% | +$381K |
|
|
CHMI
2131
Cherry Hill Mortgage Investment Corp
CHMI
$108M
| $844K | ﹤0.01% |
92,365
+50,333
| +120% | +$469K |
|
|
EARN
2132
Ellington Residential Mortgage REIT
EARN
$166M
| $844K | ﹤0.01% |
64,754
-28,055
| -30% | -$331K |
|
2133
PUT
McCormick & Company Non-Voting
MKC
$14.6B
| $841K | ﹤0.01% |
8,800
+2,800
| +47% | +$264K |
|
2134
Spero Therapeutics
SPRO
$71.6M
| $841K | ﹤0.01% |
+43,373
| New | +$676K |
|
|
SDC
2135
PUT
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $841K | ﹤0.01% |
70,400
+28,600
| +68% | +$324K |
|
2136
PUT
HF Sinclair
DINO
$16.6B
| $840K | ﹤0.01% |
32,500
-7,100
| -18% | -$161K |
|
2137
Westlake Corp
WLK
$9.56B
| $840K | ﹤0.01% |
10,298
+6,910
| +204% | +$516K |
|
2138
PUT
Cincinnati Financial
CINF
$26.3B
| $839K | ﹤0.01% |
9,600
+1,200
| +14% | +$95.8K |
|
2139
Q2 Holdings
QTWO
$3.98B
| $839K | ﹤0.01% |
6,630
-63,232
| -91% | -$6.81M |
|
2140
Tootsie Roll Industries
TR
$3.11B
| $838K | ﹤0.01% |
33,675
-24,128
| -42% | -$621K |
|
2141
PUT
Ubiquiti
UI
$34.9B
| $836K | ﹤0.01% |
3,000
-100
| -3% | -$23K |
|
2142
Hilton Worldwide
HLT
$74.1B
| $834K | ﹤0.01% |
7,495
-5,554
| -43% | -$550K |
|
2143
CALL
Coherent
COHR
$56.4B
| $828K | ﹤0.01% |
10,900
-30,700
| -74% | -$1.82M |
|
2144
iShares China Large-Cap ETF
FXI
$4.24B
| $828K | ﹤0.01% |
17,843
+8,143
| +84% | +$372K |
|
2145
Datadog
DDOG
$80.1B
| $827K | ﹤0.01% |
8,400
-38,878
| -82% | -$3.88M |
|
2146
PUT
M&T Bank
MTB
$34.7B
| $827K | ﹤0.01% |
6,500
-500
| -7% | -$56.9K |
|
2147
PUT
Ovintiv
OVV
$17.8B
| $827K | ﹤0.01% |
57,600
+26,700
| +86% | +$313K |
|
2148
CALL
Albemarle
ALB
$15.7B
| $826K | ﹤0.01% |
+5,600
| New | +$665K |
|
2149
CALL
Fastenal
FAST
$57.7B
| $825K | ﹤0.01% |
33,800
+9,600
| +40% | +$226K |
|
|
CLLS
2150
Cellectis
CLLS
$344M
| $824K | ﹤0.01% |
+30,435
| New | +$683K |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.